Oh et al., 2000 - Google Patents
Activities of synthetic hybrid peptides against anaerobic bacteria: aspects of methodology and stabilityOh et al., 2000
View PDF- Document ID
- 17210974276978375651
- Author
- Oh H
- Hedberg M
- Wade D
- Edlund C
- Publication year
- Publication venue
- Antimicrobial agents and chemotherapy
External Links
Snippet
The increasing problem of antibiotic resistance among pathogenic bacteria requires development of new antimicrobial agents. One line of investigation is the synthesis of antimicrobial hybrid peptides. The aim of the present investigation was to determine the in …
- 108090000765 processed proteins & peptides 0 title abstract description 44
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Oh et al. | Activities of synthetic hybrid peptides against anaerobic bacteria: aspects of methodology and stability | |
Rollins-Smith et al. | Activities of temporin family peptides against the chytrid fungus (Batrachochytrium dendrobatidis) associated with global amphibian declines | |
Weidenmaier et al. | DltABCD-and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model | |
Scott et al. | Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria | |
Sigurdardottir et al. | In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37 | |
Yu et al. | Easy strategy to increase salt resistance of antimicrobial peptides | |
Stark et al. | Cationic hydrophobic peptides with antimicrobial activity | |
Suarez et al. | Structure-function characterization and optimization of a plant-derived antibacterial peptide | |
Kupferwasser et al. | Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus | |
Yan et al. | Two hits are better than one: membrane-active and DNA binding-related double-action mechanism of NK-18, a novel antimicrobial peptide derived from mammalian NK-lysin | |
Ge et al. | In vitro antibacterial properties of pexiganan, an analog of magainin | |
Chen et al. | Role of peptide hydrophobicity in the mechanism of action of α-helical antimicrobial peptides | |
Jacobs et al. | NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi | |
Giacometti et al. | In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically | |
Conlon et al. | Isolation of peptides of the brevinin‐1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii | |
Mataraci et al. | In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms | |
Deslouches et al. | De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity | |
Friedrich et al. | Salt-resistant alpha-helical cationic antimicrobial peptides | |
Deslouches et al. | Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications | |
Cho et al. | Activity of protegrins against yeast-phase Candida albicans | |
Rudolph et al. | Identification of RNase 8 as a novel human antimicrobial protein | |
Singh et al. | Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities | |
Zhao et al. | Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates | |
Giacometti et al. | Potential therapeutic role of cationic peptides in three experimental models of septic shock | |
Anderson et al. | Antimicrobial activity and bacterial-membrane interaction of ovine-derived cathelicidins |